ACE2 and COVID-19: We conducted a prospective study to compare the expression of ACE2 and TMPRSS2 in the nasal and paranasal sinus tissues among patients with COVID-19-associated mucormycosis, COVID-19-negative mucormycosis (CNM), and healthy individuals.